Akcea Plunges as Analysts Fear Wider Fallout From Drug Setback

(Bloomberg) -- Akcea Therapeutics Inc. and Ionis Pharmaceuticals Inc. got a rude surprise last night after the Food and Drug Administration issued a complete response letter on their Waylivra, foll...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.